Barriers to fulfilling patient education recommendations

Common barriers to providing recommended patient education are lack of time or training. INTRODUCTION Inflammatory arthritis is a group of diseases including spondyloarthritis, rheumatoid arthritis, and psoriatic arthritis. These are chronic inflammatory diseases that affects a person’s joints, and may cause pain and disability. Patient education is a planned interactive learning process designed to support […]

Read More…

High steroid-free success rates after glucocorticoid bridging

90% of people with early rheumatoid arthritis are steroid-free 2 years after bridging therapy INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. Rheumatoid arthritis […]

Read More…

Full vaccination course is necessary for efficient response

People with inflammatory arthritis may have impaired response to the first dose but excellent final responses to mRNA vaccines. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced […]

Read More…

Medication use for rheumatoid arthritis affects COVID-19 outcomes

People with rheumatoid arthritis treated with rituximab or JAKi have worse COVID-19 severity than those on TNFi INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to […]

Read More…

Arthritis induced by cancer therapy may persist after stopping treatment

Inflammatory arthritis caused by immune checkpoint inhibitor drugs can become a long-term problem, but it can be treated. Introduction Immune checkpoint inhibitors are a type of immunotherapy used to treat cancer. There are several drugs in this group, and they are used in more than 10 cancer types. This type of treatment for cancer is […]

Read More…

The role of the nurse in inflammatory arthritis

This is the lay version of the updated EULAR recommendations for the role of the nurse in managing chronic inflammatory arthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Bech B, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. […]

Read More…

Physical activity

This is the lay version of the EULAR recommendations for physical activity in people with inflammatory arthritis or osteoarthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Rausch Osthoff AK, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018;77:1251–1260 doi:10.1136/annrheumdis-2018-213585 Introduction EULAR […]

Read More…

Cancer drugs may trigger inflammatory arthritis

Immune checkpoint inhibitors may trigger the development of rheumatoid arthritis or polymyalgia rheumatica in some patients, but it can be treated. INTRODUCTION Inflammatory arthritis develops when the immune system starts to attack the body’s own tissues. Inflammatory arthritis is an umbrella term for a group of chronic inflammatory diseases that affect a person’s joints, causing […]

Read More…

Vaccination for people with autoimmune inflammatory rheumatic diseases

Introduction Vaccinations are a way of preventing infections before they happen. Vaccines help the immune system to recognise viruses and bacteria that cause disease. Recommendations give advice to doctors and patients about the best way to treat and manage diseases. EULAR published in 2011 the current recommendations on vaccination for people with autoimmune inflammatory rheumatic […]

Read More…